Werbung
Kursziele der Pfizer-Aktie
*Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Pfizer-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 44,00$ | -0,25% | 14.09.22 | |
| Barclays Capital | 50,00$ | +13,35% | 30.08.22 | |
| UBS AG | 59,00$ | +33,76% | 26.08.22 | |
| Goldman Sachs Group Inc. | 50,00$ | +13,35% | 26.08.22 | |
| JP Morgan Chase & Co. | 57,00$ | +29,22% | 28.06.22 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 3 | 1 | 107,06 £ | - |
| Bayer | 12 | 1 | 0 | 78,75 € | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| EVOTEC SE | 5 | 0 | 1 | 37,17 € | +101,79% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 8 | 0 | 16,59 £ | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 5 | 1 | 213,18 € | +26,14% |
| MorphoSys | 2 | 4 | 0 | 43,92 € | +106,49% |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 2 | 4 | 4 | 86,60 CHF | - |
| Perrigo Company | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 4 | 0 | 52,00 $ | +17,89% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 7 | 4 | 0 | 107,04 € | +35,96% |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |